BioMedNewsBreaks – CB Scientific Inc. (CBSC) Announces Significant Growing Interest in Its my-Cam and my-Cardia Solutions

December 28, 2020 11:42:00

CB Scientific (OTC: CBSC), a provider of innovative products and services for the ambulatory noninvasive cardiac monitoring space, today announced the addition of dozens of new clinical trials of its my-Cam device and new hospital monitoring contracts through the company’s exclusive authorized distributor, Mango Wellness Co. Ltd. (“MWC”) and My Cardia Thailand Co. Ltd. (“MCT”) in Thailand. According to the update, MWC’s successful participation as an exhibitor at the Royal College of Physicians of Thailand Annual Conference in Pattaya, Thailand, Oct. 29-31, and again at the Thailand Cardiologist Annual Conference in Hua Hin, Thailand, Dec. 10-12, produced overwhelming interest. More than 160 physicians have requested on-site evaluations of the company’s innovative my-Cam monitor and my-Cardia software portal in these two regions of Thailand.  MWC and MCT anticipate adding 100 contracted hospitals in the first quarter of 2021, totaling more than 1,000 ambulatory remote cardiac event monitoring tests during this time.

To view the full press release, visit https://ibn.fm/5joab

About CB Scientific Inc.

CB Scientific is a publicly traded company that, through its U.S. and international subsidiaries, provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. For more information about the company, visit www.CBScientificInc.com.

About BioMedWire

BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork